In a report released on April 10, Shane Storey from Wilsons maintained a Buy rating on PYC Therapeutics Limited (PYC – Research Report), with a price target of A$3.00. The company’s shares ...

Perth-based PYC Therapeutics is battling to complete its $146 million capital raising after a large shortfall from retail investors and a “liquidity” issue by one of its underwriters. The lack of ...

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return PYC.AX S&P/ASX 200 [XJO] (^AXJO) ...